摘要
Objective To compare the long-term efficacy of microwave ablation (MWA) for subcapsular and non-subcapsular hepatocellular carcinomas (HCCs) using propensity score matching (PSM). Materials and methods Using a multicenter database, we enrolled 430 patients (347 men, 83 women; age range, 15-71 years) with HCCs who received percutaneous ultrasound-guided MWA, between January 2012 and December 2018. The patients were grouped as follows, based on whether the tumor was adjacent to the capsule: subcapsular group (n = 142) and non-subcapsular group (n = 142). To evaluate the correlation between subcapsular position and efficacy of MWA, a Cox proportional hazards model was used to calculate disease-free survival (DFS) and overall survival (OS) based on PSM data. Results In total, 142 pairs of patients were matched. In the PSM cohort, the 1-year, 3-year, and 5-year DFS rates of the subcapsular and non-subcapsular groups were 84%, 61%, and 47%, respectively, and 85%, 67%, and 58%, respectively, while the 1-year, 3-year, and 5-year OS rates were 98%, 90%, and 84%, respectively, and 98%, 90%, and 88%, respectively. In the PSM cohort, subcapsular position was not an independent risk factor for DFS (hazard ratio [HR] = 1.291, p = 0.196) or OS (HR = 0.926, p = 0.866). Additionally, there were no significant differences in the incidence of local tumor progression, major complications, technical success rate, number of puncture needles, and postoperative hospital stay between the two groups (p > 0.05). Conclusion There were no significant differences in DFS, OS, incidence of local tumor progression, and major complications between patients with subcapsular and non-subcapsular HCCs treated with MWA.
学科与关键词
- Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching studyLi, Lijuan; Yao, Jundong; Yan, Xizi; Qi, Xiaoguang; Liang, Ping; Han, Zhiyu; Liu, Fangyi; Cheng, Zhigang; Luo, Yanchun; Zheng, Rongqin; Cheng, Wen; Wei, Qiang; Yu, Songyuan; Yu, Jie*; Yu, Xiaoling*International Journal of Hyperthermia, 2023, 40(1): 2248425.
- Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric ExperienceYu, Jie; Cheng, Zhi-Gang; Han, Zhi-Yu; Liu, Fang-Yi; Zheng, Rong-Qin; Cheng, Wen; Wei, Qiang; Yu, Song-Yuan; Li, Qin-ying; He, Guang-zhi; Luo, Yan-chun; Yu, Xiao-Ling; Liang, Ping*Liver Cancer, 2022, 11(4): 341-353.被引 9
- Learning curve of microwave ablation for liver cancersDou, Jianping; Yu, Jie; Cheng, Wen; Wei, Qiang; Luo, Yanchun; Han, Zhiyu; Cheng, Zhigang; Liu, Fangyi; Yu, Xiaoling; Liang, Ping*EUROPEAN JOURNAL OF RADIOLOGY, 2023, 158: 110613.被引 1
